Neurology Today Editor-in-chief Joseph E. Safdieh highlights the news source’s focus on neurology—clinical and basic research, policy, and professionalism issues—and neurologists.
Professionalism Highlights of Neurology Today With Dr. Joseph E. Safdieh Legend: Neurology Today Editor-in-chief Joseph E. Safdieh highlights the news source’s focus on neurology—clinical and basic research, policy, and professionalism issues—and neurologists. Duration: 4:33 Associated with: Published on: July 19, 2023
Artificial Intelligence Identifies Early Ischemia on Non-contrast CT Legend: In this video, Matthew Hart, MD, discusses a report on teleneurology—finding it improved access to neurologist appointments and reduced wait times in the emergency department—with Neurology Today editor-in-chief Joseph E. Safdieh, FAAN. He presented the findings at the 2022 AAN Annual Meeting. For the full report, visit https://bit.ly/AANAM-teleneurology. Duration: 5:30 Associated with: Published on: June 13, 2022
Artificial Intelligence Identifies Early Ischemia on Non-contrast CT Legend: In this video, James Hillis, MD, discusses an artificial intelligence algorithm that identified early ischemia on non-contrast CT more accurately than expert neuroradiologists with Neurology Today editor-in-chief Joseph E. Safdieh, FAAN. He presented the findings at the 2022 AAN Annual Meeting. For the full report, visit https://bit.ly/AANAM-AI-ischemia." Duration: 7:07 Associated with: Published on: June 13, 2022
Diversity Child Neurology Society: Disparities in Treatment for Infantile Spasms Legend: Watch this video on disparities in treatment for infantile spasms: Neurology Today Editorial Board Member Ann Tilton, MD, FAAN, interviews Fiona M. Baumer, MD, a pediatric neurologist at Stanford. In a platform presentation at the Child Neurology Society annual meeting, Dr. Baumer presented new data showing disparities in treatment for infantile spasms between Black and White children. Whether they had public or private insurance seemed to be associated with the treatment they received. For more on the findings, visit https://bit.ly/3lIvzzi Duration: 9:10 Associated with: Published on: October 28, 2021
In the Pipeline Child Neurology Society: Pain Relief for Treatment-Refractory Pediatric Headaches Legend: Watch this video on a novel pain management approach for treatment-refractory pediatric headaches. Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, interviews Sara Pavitt, MD. about her poster presentation at the Child Neurology Society annual meeting. Dr. Pavitt presented new data showing that children with refractory headache disorders experienced pain relief when treated with intravenous sodium valproate that included a three- to four-day hospitalization. For more on the findings, visit https://bit.ly/3aFm51M Duration: 5:06 Associated with: Published on: October 28, 2021
In the Pipeline Child Neurology Society: Gene Therapy for Cerebral Adrenoleukodystrophy Legend: Watch this video on a novel gene therapy for cerebral adrenoleukodystrophy: Neurology Today Editorial Board member Temitayo Oyegbile-Chidi, MD, PhD, interviews Florian Eichler, MD, about his platform presentation at the Child Neurology Society annual meeting. Dr. Eichler presented new data showing that neurologic function stabilized in boys with cerebral adrenoleukodystrophy who received elivaldogene autotemcel, a novel lenti-D vector gene therapy. For more on the findings, visit https://bit.ly/3oYQoZz Duration: 7:14 Associated with: Published on: October 28, 2021
A Mentoring Program Is a Draw for Underrepresented Students Legend: Neurology Today At the American Academy of Neurology Annual Meeting: A mentoring program that provides support for research and education on neurology as early as high school could potentially be a powerful tool for increasing interest in the specialty among underrepresented students. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Madison Ellin, MS, a program coordinator at Massachusetts General Hospital in Boston, about the program. Read the full report with Neurology Today At the Meetings: https://bit.ly/3eBeuD1 Duration: 3:07 Associated with: Published on: April 29, 2021
Efgartigimod Was Well-Tolerated in Patients with Generalized Myasthenia Gravis Legend: Neurology Today At the American Academy of Neurology Annual Meeting: Efgartigimod was safe and effective for patients with generalized myasthenia gravis. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews James F. Howard Jr, MD, FAAN, professor of neurology at the University of North Carolina in Chapel Hill, about the clinical implications of the research. Read the full report: https://bit.ly/3avecwb. Duration: 6:03 Associated with: Published on: April 26, 2021
Cenobamate Shows Long-Term Benefits for Focal Seizures Legend: Neurology Today At the American Academy of Neurology Annual Meeting: Cenobamate leads to sustained, long-term seizure freedom from focal epilepsy in many patients who were refractory to other treatments. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Michael Sperling, MD, FAAN, professor of neurology at Thomas Jefferson University, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3sMgH3z. Duration: 6:14 Associated with: Published on: April 23, 2021
Atogepant Reduces Number of Mean Monthly Migraines Legend: Neurology Today At the American Academy of Neurology Annual Meeting: People with migraine who took atogepant, an orally administered calcitonin gene-related peptide receptor antagonist, had an average of three to four fewer migraines each month. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Jessica Ailani, MD, FAAN, director of MedStar Georgetown Headache Center and professor of clinical neurology in the department of neurology at Medstar Georgetown University in Washington, DC, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3dBUNvm. Duration: Associated with: Published on: April 23, 2021
Estrogen-Modulating Therapies Associated with Lower Risk of Dementia in Breast Cancer Patients Legend: Neurology Today At the American Academy of Neurology Annual Meeting: Women with breast cancer who were taking tamoxifen and steroidal aromatase inhibitors had a decreased risk for a neurogenerative disease, specifically Alzheimer's disease and dementia. Neurology Today Editor-in-Chief Joseph E. Safdieh interviews Gregory Branigan, a graduate student researcher at the University of Arizona College of Medicine, about the clinical implications of the research. Read the full report with Neurology Today At the Meetings: https://bit.ly/3sye70E. Duration: 4:00 Associated with: Published on: April 21, 2021
COVID19: Wellness Strategies Legend: COVID-19: In this video, Joseph E. Safdieh, MD, FAAN, and Jennifer Bickel, MD, FAAN, FAHS, discuss the current state of neurologists’ wellbeing in the setting of COVID-19, the need for community, the power of gratitude, and strategies for recognizing distress and encouraging wellness. For more coverage on these issues, read “The Emotional Fallout of the Pandemic on Our Neurology Workforce” and “The Neurologists Are Not Alright,” a call to action from the editors of Neurology Today. Duration: 10:23 Associated with: Neurology Today. 21(2):18-19, January 21, 2021 Neurology Today. 21(2):18, January 21, 2021 Published on: February 04, 2021
COVID19: Burnout/Wellness Strategies for Neurologists Legend: COVID-19: Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, and Neil A. Busis, MD, FAAN, discuss the impact of COVID-19 on burnout and strategies to address it. For more coverage on these issues, read “The Emotional Fallout of the Pandemic on Our Neurology Workforce” and “The Neurologists Are Not Alright,” a call to action from the editors of Neurology Today. Duration: 8:23 Associated with: Neurology Today. 21(2):18-19, January 21, 2021 Neurology Today. 21(2):18, January 21, 2021 Published on: February 02, 2021
COVID-19: Separating Fact from Fiction – An Update Legend: COVID-19: In this video, Sherry H-Y. Chou, MD, M.Sc, FNCS, FCCM, joins Richard S. Isaacson, MD, FAAN, for an update on the Global Consortium to Study Neurological Dysfunction in COVID-19. They discuss the progress of the consortium, questions that remain as the COVID-19 pandemic continues, and the goals and outcomes for the research. Duration: 28:13 Associated with: Published on: September 20, 2020
Health Care Provider Burnout in the Era of COVID-19 Legend: COVID-19: Richard S. Isaacson, MD, FAAN, and Neil A. Busis, MD, FAAN, discuss physician burnout, how burnout is changing for health care workers, the increase in institutional wellness programs, and the impact of telemedicine in the setting of COVID-19. Duration: 24:18 Associated with: Published on: July 29, 2020
COVID-19: Health Care Disparities Legend: COVID-19: Richard S. Isaacson, MD, FAAN and Richard T. Benson, MD, PhD, discuss why COVID-19 is disproportionately affecting minorities communities, how the NIH is dealing with the health care disparities across the US, and ways AAN members can address these disparities within their institutions. . Duration: 25:03 Associated with: Published on: July 29, 2020
COVID-19: Leading During a Crisis Legend: COVID-19: Richard S. Isaacson, MD, FAAN, and Rachel Marie E. Salas, MD, MEd, FAAN, discuss how to lead others by being adaptive, the importance of getting a good night’s rest, and the tools leaders in neurology are relying on amid the COVID-19 pandemic. Duration: 20:20 Associated with: Published on: July 29, 2020
COVID-19: Wellness in the Age of COVID-19_Meditation Legend: COVID-19: Richard S. Isaacson, MD, FAAN and transcendental meditation expert, Bob Roth discuss forms of meditation to manage the ongoing trauma and stress health care workers are dealing with in the setting of COVID-19. Duration: 34:09 Associated with: Published on: July 29, 2020
COVID19: Online Learning Opportunities from the AAN Legend: COVID-19: In this video, Richard S. Isaacson, MD, FAAN, discusses the online learning opportunities offered by the AAN during the COVID-19 pandemic. Duration: 14:49 Associated with: Published on: May 20, 2020
Professionalism The Impact of COVID-19 on Neurology Medical Education Legend: COVID-19: In this video, Richard S. Isaacson, MD, FAAN, discusses with Jaffar Khan, MD, FAAN, how the coronavirus pandemic is affecting medical education and residencies. For more discussion on the state of neurology medical education during COVID-19, link to https://bit.ly/2WfBuya. Duration: 21:49 Associated with: Neurology Today. 20(8):14-15, April 16, 2020 Published on: May 12, 2020
COVID19–CNN Medical Correspondent Sanjay Gupta, MD, reports on what’s known to date. Legend: COVID-19: CNN Chief Medical Correspondent Sanjay Gupta, MD, associate chief of neurosurgery at Grady Memorial Hospital in Atlanta, provides an overview of what’s known to date on COVID-19 with Richard S. Isaacson, MD, FAAN, of Weill Cornell Medicine. For complete Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 23:46 Associated with: Published on: April 21, 2020
COVID19–How to Talk About COVID-19 With Your Patients Legend: COVID-19: Orly Avitzur, MD, MBA, FAAN, editor-in-chief of Brain and Life and associate editor of Neurology Today, discusses the messaging for discussing COVID-19 with patients with Richard S. Isaacson, MD, FAAN, For Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 14:06 Associated with: Published on: April 21, 2020
COVID19–How a Neurology Chair Manages COVID-19 Legend: COVID-19: Ralph L. Sacco, MD, MS, FAHA, FAAN, chair of neurology at the University of Miami Miller School of Medicine, discusses what it takes to manage a neurology department during COVID-19 with Richard S. Isaacson, MD, FAAN. For Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 12:41 Associated with: Published on: April 20, 2020
COVID19–Neurologists on Surviving a Quarantine Legend: COVID-19: Janis M. Miyasaki, MD, MEd, FRCPC, FAAN, and Brenda L. Banwell, MD, FAAN, were quarantined during the SARS outbreak. They share what they learned with Richard S. Isaacson, MD, FAAN, For Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 13:51 Associated with: Published on: April 20, 2020
COVID19–Wellness in the Age of COVID-19 Legend: COVID-19: Richard S. Isaacson, MD, FAAN, of Weill Cornell Medicine discusses with Neurology Today Editorial Board Member Jennifer Bickel, MD, FAAN, tips for wellness in the setting of COVID-19. For Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 27:36 Associated with: Published on: April 20, 2020
COVID19–What Every Practicing Physician Should Know Legend: COVID-19: Neurology Today’s Editor-in-Chief Joseph E. Safdieh, MD, FAAN and Richard S. Isaacson, MD, of Weill Cornell Medicine discuss the impact of COVID-19 on neurologists in community practice. For Neurology Today complete coverage of COVID-19, visit https://journals.lww.com/neurotodayonline/topics/COVID-19 Duration: 25:00 Associated with: Published on: April 20, 2020
Professionalism The Impact of COVID19 on AAN Programs and Services Legend: COVID-19: AAN President James C. Stevens, MD, FAAN, says COVID-19 will not stop AAN CME activities, the release of Annual Meeting abstracts, and other programs and services. Duration: 21:03 Associated with: Published on: April 16, 2020
For Your Patients COVID19-How The Pandemic Is Impacting Neurology Legend: COVID-19: Neurology Today’s Editor-in-Chief Joseph E. Safdieh, MD, FAAN and Richard S. Isaacson, MD, of Weill Cornell Medicine discuss the impact of COVID-19 on neurology. Read the full reports at Neurology Today: https://journals.lww.com/neurotodayonline/pages/default.aspx Duration: 14:49 Associated with: Published on: April 01, 2020
In the Pipeline A Prophylactic Therapy for Tuberous Sclerosis Legend: Neurology Today At the AES Annual Meeting: A preventive epilepsy treatment reduced the risk of seizures and intellectual disability in school-aged children with tuberous sclerosis. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-tuberoussclerosis. Duration: 7:15 Associated with: Published on: January 29, 2020
For Your Patients Smartphone Videos Help Identify Seizures Remotely Legend: Neurology Today At the AES Annual Meeting: Smartphone videos from patients with epilepsy were accurate for diagnosing seizures about 80 percent of the time. Read the full report at Neurology Today At the Meetings: http://bit.ly/NT-ATM-phone. Duration: 7:39 Associated with: Published on: January 29, 2020
Disease Mechanisms Antibodies Identified in Autoimmune Epilepsy Legend: Neurology Today At the AES Annual Meeting: Screening for antibodies may help identify potential therapeutic targets for epilepsy. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-antibodies Duration: 4:45 Associated with: Published on: January 29, 2020
Disease Mechanisms Somatic Mutations Linked to Tuberous Sclerosis Legend: Neurology Today At the AES Annual Meeting: Somatic mutations in the mTOR pathway are associated with epileptiform syndromes. Read the full report with Neurology Today At the Meetings: http://bit.ly/ATM-mTOR Duration: 3:29 Associated with: Published on: January 23, 2020
For Your Patients New Questions About Starting Epilepsy Patients on Levetiracetam Legend: Neurology Today At the AES Annual Meeting: Should Epilepsy Patients Be Started on Levetiracetam? A new report found that patients initially started on levetiracetam often switched to another agent, mostly due to mood alterations. Read the full report with Neurology Today At the Meetings: http://bit.ly/ATM-firsttherapy Duration: 5:02 Associated with: Published on: January 23, 2020
For Your Patients How Often Do Children with Infantile Spasms Receive First-line Therapy? Legend: Neurology Today At the AES Annual Meeting: A new report found that infants with infantile spasms receive first-line therapy most of the time, but there is still variability among centers nationwide. Read the full report with Neurology Today At the Meetings: http://bit.ly/ATM-infantilespasms. Duration: 4:45 Associated with: Published on: January 23, 2020
In the Pipeline A Deep Learning Algorithm for Identifying Focal Cortical Dysplasia-Causing Seizures Legend: Neurology Today At the AES Annual Meeting: An algorithm had an overall sensitivity of 87 percent in detecting focal cortical dysplasia lesions. Read the full report withNeurology Today At the Meetings: http://bit.ly/NT-ATM-cortical. Duration: 4:45 Associated with: Published on: January 23, 2020
Policy and Practice Opioids Are Often Prescribed for Migraine Across All Age Groups Legend: Neurology Today At the American Headache Society Annual Meeting: Three different studies suggest that opioids are often prescribed to patients of all ages—ranging from 23 percent to 36.3 percent of the time—as a first-line therapy. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-opioids-migraine Duration: 3:53 Associated with: Neurology Today. 19(16):1,24-30, August 22, 2019 Published on: September 03, 2019
For Your Patients Telemedicine for Migraine Management Legend: Neurology Today At the American Headache Society Annual Meeting: Treating patients with migraine via telemedicine techniques appears to deliver the same quality of care as in-office visits. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-AHS-telemedicine Duration: 4:11 Associated with: Published on: September 03, 2019
For Your Patients Mindfulness Techniques Reduce Migraine-Related Disability Legend: Neurology Today At the American Headache Society Annual Meeting: Migraineurs who practice mindfulness techniques appear to experience less headache-related disability. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-AHS-mindfulness Duration: 4:49 Associated with: Published on: September 03, 2019
For Your Patients Rimegepant Is Effective for Acute Migraine Pain at 2 Hours Legend: Neurology Today At the American Headache Society Annual Meeting: Migraine patients treated with rimegepant, a CGRP receptor antagonist, were free from pain and free from their most bothersome symptom two hours after the dose compared with placebo. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-AHS-vasoconstrictive Duration: 2:33 Associated with: Published on: August 27, 2019
Policy and Practice Opioids Use in the Emergency Department for Migraine Treatment in Adolescents and Young Adults Legend: Neurology Today At the American Headache Society Annual Meeting: Adolescents and young adults who present at the emergency department with migraine-like attacks are frequently treated with opioids for their painful headaches. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-AHS-opioids Duration: 1:59 Associated with: Published on: August 27, 2019
Disease Mechanisms Genetic Mutations in Childhood-Onset Dystonia Legend: Neurology Today At the AAN Annual Meeting: What researchers now know about the genetics underlying childhood-onset dystonia. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-dystonia Duration: 3:03 Associated with: Published on: July 16, 2019
Disease Mechanisms Neuronal Antibodies in Patients with Focal Epilepsy of Unknown Origin Legend: Neurology Today At the AAN Annual Meeting: Researchers found neuronal antibodies in patients diagnosed with epilepsy of unknown origin—how and why this could impact treatment. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-neuronalantibodies Duration: 3:15 Associated with: Published on: July 16, 2019
For Your Patients Wearable Smartphone-Based EEG for Pediatric Epilepsy Patients in Guinea Legend: Neurology Today At the AAN Annual Meeting: A smartphone app for an EEG helped detect epileptiform abnormalities in a rural West African country—how it may help in other rural areas. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-smartphone Duration: 4:39 Associated with: Published on: July 16, 2019
Professionalism Missed Vascular Events in the US: Incidence, Settings, and Causes Legend: Neurology Today At the AAN Annual Meeting: Nearly one-fifth of vascular events, particularly strokes, are misdiagnosed or missed. Read the full report here: http://bit.ly/NT-vascular Duration: 3:25 Associated with: Published on: July 16, 2019
Disease Mechanisms Neurofilament Light Chain Levels Predictor of Radiologically Syndrome to Multiple Sclerosis Legend: Neurology Today At the AAN Annual Meeting: Do neurofilament light chain levels predict conversion from radiologically syndrome to multiple sclerosis? Read the full report here: http://bit.ly/NfL-MS Duration: 4:34 Associated with: Published on: July 16, 2019
Disease Mechanisms Association of MS Meningeal Inflammation Markers with Cortical Lesions Legend: Neurology Today At the AAN Annual Meeting: Using 7-Tesla MRI, researchers found no strong relationship between biomarkers of meningeal inflammation and cortical lesions in patients with multiple sclerosis. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-MS Duration: 3:35 Associated with: Published on: July 15, 2019
Professionalism How Often Neurology Residents Get the Diagnosis Right or Wrong Legend: Neurology Today At the AAN Annual Meeting: New findings offer an unusual look at the broad array of cases that are seen in neurology residency, showing how often residents get things right or wrong. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-residents Duration: 2:35 Associated with: Published on: July 15, 2019
At the Bench A Cell Therapy Appears Promising for Inherited Metabolic Disorders in Children Legend: Neurology Today At the AAN Annual Meeting: Scientists have developed a method of expanding hematopoietic stem cells greater than 300-fold over standard methods to treat selected inherited metabolic disorders in children. Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-ATM-stemcell Duration: 3:36 Associated with: Published on: July 15, 2019
For Your Patients Women with Epilepsy Can Switch Drugs for Pregnancy Legend: Neurology Today At the AAN Annual Meeting: Women with epilepsy who want to have a baby can successfully switch from valproic acid, a known cause of birth defects, to a less teratogenic medication without a major risk of breakthrough seizures. Read the full report with Neurology Today At the Meetings: http://bit.ly/ATM-NT-epilepsy Duration: 4:39 Associated with: Published on: July 15, 2019
